Stay updated with breaking news from Cell Collection Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Contrasts EsoCheck's powerful cell collection capabilities to cruder, decades-old technologies during comments on patient access to medical technology innovation NEW YORK, Feb. 15, 2024 /PRNewswire/...
Multicenter observational study documents excellent concordance of EsoGuard results with subsequent medical decision-making by multiple physicians NEW YORK, Sept. 7, 2023 /PRNewswire/ -- Lucid...
Study documents 100 percent concordance between EsoGuard® test results and subsequent medical decision-making Timely results support recently proposed federal legislation which seeks to fund...
/PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...
/PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...